Composés 18-hydroxylés plasmatiques (18-hydroxycorticostérone, 18-hydroxydésoxycorticostérone) : méthode de dosage et applications cliniques dans certaines pathologies surrénaliennes

Abdelhamid, 1981, Elevated «free 18-hydroxycorticosterone excretion as a possible indicators for early diagnosis of primary aldosteronism, J. Steroid Biochem., 14, 913, 10.1016/0022-4731(81)90240-5 Aupetit, 1977, Caractère enzymatique et localisation subcellulaire de la réaction de transformation de la 18-hydroxycorticostérone en aldostérone, Biochimie, 59, 705, 10.1016/S0300-9084(77)80249-6 Aupetit, 1979, Cytochrome P450 et transformation de la 18-hydroxycorticostérone en aldostérone, Biochimie., 61, 1085, 10.1016/S0300-9084(80)80263-X Aupetit, 1980, Relation between energy metabolism in mitochondria and conversion of 18-hydroxycorticosterone to aldosterone in adrenals, Biochimie, 62, 823, 10.1016/S0300-9084(80)80138-6 Aupetit, 1983, The final step of aldosterone biosynthesis requires reducing power : it is not a dehydrogenation, Biochem. Biophys. Acta, 752, 73, 10.1016/0005-2760(83)90234-5 Aupetit, 1986, Stimulation of oxygen consumption at the cytochrome a3 level inhibits aldosterone biosynthesis from 18-hydroxycorticosterone, Biochem. Biophys. Acta, 884, 270, 10.1016/0304-4165(86)90173-X Biglieri, 1979, The significance of elevated levels of plasma 18-hydroxycorticosterone in patients with primary aldosteronism, J. Clin. Endocrinol. Metab., 49, 87, 10.1210/jcem-49-1-87 Braley, 1984, The effects of extracellular K+ and angiotensin II on cytosolic Ca++ and steroidogenesis in adrenal glomerulosa cells, Biochem. Biophys. Res. Commun., 123, 810, 10.1016/0006-291X(84)90302-4 Dale, 1976, Radioimmunoassay of 18-hydroxy-11-deoxycorticosterone in plasma, J. Clin. Endocrinol. Metab., 43, 803, 10.1210/jcem-43-4-803 Di Matteo, 1972, Hypertension artérielle et hyperplasie surrénale congénitale par déficit en 11-b hydroxylase, Cœur et Med. Interne, 11, 187 Drop, 1982, The effect of ACTH stimulation on plasma steroids in 2 patients with congenital hypoaldosteronism and in their relatives, Acta Endocrinol., 99, 245, 10.1530/acta.0.0990245 Ferriss, 1983, Primary aldosterone excess : Conn's syndrome and similar disorders, Vol. 2, 132 Fraser, 1978, 18 OH. B a review, J. Steroid Biochem., 9, 273, 10.1016/0022-4731(78)90161-9 Fraser, 1981, Response of aldosterone and 18-hydroxycorticosterone to angiotensine II in normal subjects and patients with essential hypertension, Conn's syndrome and non tumorous hyperaldosteronism, Hypertension, 3, 187, 10.1161/01.HYP.3.3_Pt_2.I87 Fraser, 1983, Inborn errors of corticosteroid biosynthesis : their effects on electrolyte metabolism and blood pressure, Vol. 2 Ganguly, 1981, Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations, J. Clin. Endocrinol. Metab., 53, 1040, 10.1210/jcem-53-5-1040 Grekin, 1973, The role of 18-hydroxy-11-deoxycorticosterone as a precursor in human adrenal tissue in vitro, J. Clin. Endocrinol. Metab., 37, 261, 10.1210/jcem-37-2-261 Hamilton, 1976, Hypoaldosteronism in three sibs due to 18-dehydrogenase deficiency, Arch. Dis. Child., 51, 576, 10.1136/adc.51.8.576 Honda, 1978, Plasma levels of 18-hydroxy-11-deoxycorticosterone in essential hypertension, Endocrinol. Jpn., 25, 237, 10.1507/endocrj1954.25.237 Hornung, 1978, Radioimmunoassay of free urinary 18-hydroxydeoxycorticosterone (18-OH-DOC) in patients with essential hypertension, Clin. Chem. Acta, 87, 181, 10.1016/0009-8981(78)90337-6 Huston, 1981, Evaluation of the mineralocorticoid activity of 18-hydroxycorticosterone, Clin. Sci., 61, 201, 10.1042/cs0610201 Isles, 1987, Hypermineralocorticoidism due to adrenal carcinoma : plasma corticosteroids and their response to ACTH and angiotensin II, Clin. Endocrinol., 26, 239, 10.1111/j.1365-2265.1987.tb00782.x Kater, 1982, The unique patterns of plasma aldosterone and 18-hydroxycorticosterone concentrations in the 17a-hydroxylase deficiency syndrome, J. Clin. Endocrinol. Metab., 55, 295, 10.1210/jcem-55-2-295 Kater, 1985, The constant plasma 18-hydroxycorticosterone to aldosterone ratio : an expression of the efficacy of corticosterone methyl oxidase type II activity in disorders with variable aldosterone production, J. Clin. Endocrinol. Metab., 60, 225, 10.1210/jcem-60-2-225 Mason, 1977, The effect of sodium deprivation and of angiotensin II infusion on the peripheral plasma concentrations of 18-hydroxycorticosterone, aldosterone and other corticosteroids in man, J. Steroid Biochem., 8, 799, 10.1016/0022-4731(77)90086-3 Melby, 1971, 18-hydroxydeoxycorticosterone in human hypertension, Cir. Res. Supp. II, XXVIII, 143 Melby, 1972, 18-hydroxy-11-deoxycorticosterone (18- OH-DOC) secretion in experimental and in human hypertension, Recent. Progr. Horm. Res., 28, 287 Nicholls, 1979, Arterial levels and mineralocorticoid activity of 18-hydroxy-11-deoxycorticosterone in the rat, J. Steroid. Biochem., 10, 67, 10.1016/0022-4731(79)90142-0 Nowaczynski, 1975, Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension, J. Steroid. Biochem., 6, 767, 10.1016/0022-4731(75)90066-7 Reiter, 1979, Adrenal 18-dehydrogenase defect : clinical remission but chemical persistance, Pediatr. Res., 13, 384 Rosler, 1977, The nature of the defect in a salt-wasting disorder in Jews of Iran, J. Clin. Endocrinol. Metab., 44, 279, 10.1210/jcem-44-2-279 Roy, 1976, Structure and mechanism of formation of the two forms of 18-hydroxy-11-deoxycorticosterone, J. Steroid. Biochem., 7, 81, 10.1016/0022-4731(76)90139-4 Sheppard, 1963, Steroid biosynthesis by rat adrenal : functional zonation, Endocrinology, 73, 819, 10.1210/endo-73-6-819 Sowers, 1982, Dopaminergic control of 18-hydroxycorticosterone responses to posture, isometric exercise and diuretic administration in normal man, J. Clin. Endocrinol. Metab., 55, 475, 10.1210/jcem-55-3-475 Sowers, 1982, Influence of sodium homeostasis and circadian rhythm on dopaminergic modulation of 18-hydroxycorticosterone secretion in man, J. Clin. Endocrinol. Metab., 55, 1046, 10.1210/jcem-55-6-1046 Tan, 1976, The role of 11-deoxycorticosterone in human hypertension, Clin. Sci. Mol. Med., 51, 311 Tuck, 1977, The influence of ACTH, dietary sodium, upright posture and angiotensine II on plasma 18-hydroxy-11-deoxy-corticosterone levels in normal subjects, J. Clin. Endocrinol. Metab., 45, 893, 10.1210/jcem-45-5-893 Ulick, 1964, An aldosterone biosynthetic defect in a salt losing disorder, J. Clin. Endocrinol., 24, 669, 10.1210/jcem-24-7-669 Ulick, 1976, Diagnosis and nomenclature of the disorders of the terminal portion of the aldosterone biosynthetic pathway, J. Clin. Endocrinol., 43, 92, 10.1210/jcem-43-1-92 Ulick, 1976, Adrenocortical factors in hypertension : Significance of 18-hydroxy-11-deoxycorticosterone, Am. J. Cardiol., 38, 814, 10.1016/0002-9149(76)90360-X Vecsei, 1968, The intermediate role of 18-hydroxycorticosterone in aldosterone biosynthesis, Experientia, 24, 1199, 10.1007/BF02146618 Vecsei, 1982, Direct radio-immunoassay for «aldosterone and «18-hydroxycorticosterone in unprocessed urine, and their use in screening to distinguish primary aldosteronism from adrenal hyperplasia. Hypertension, Clin. Chem., 28, 453, 10.1093/clinchem/28.3.453 Vecsei, 1982, Increased excretion of 18-hydroxycorticosterone in patients with adrenal adenomas and hypertension, Clin. Exp. Hypertens. Part A Theory Pract., A4, 1759, 10.3109/10641968209061639 Veldhuis, 1980, Inborn error in the terminal step of aldosterone biosynthesis : corticosterone methyl oxidase type II deficiency of a North American Pedigree, N. Engl. J. Med., 303, 117, 10.1056/NEJM198007173030301 Watanabe, 1984, Enzyme immunoassay for serum 18-hydroxycorticosterone and its clinical application, Steroids, 43, 509, 10.1016/S0039-128X(84)90144-2 Young, 1988, Primary aldosteronism, Endocrinol. Metab. Clin. N. Am., 17, 367, 10.1016/S0889-8529(18)30425-0